The use of late preterm antenatal corticosteroids in women with gestational diabetes : a puzzle worth solving

Table 1 Demographics and basic clinical characteristics of patients in study groups

Variable	Treatment group (n: 196)	Control group (n:204)	p
Maternal age (years)	33 (28–37)	33 (29–37)	0.38
BMI (kg/m²)	31 (26–36)	32 (28–36)	0.09
Gravidity (number)	3 (2–4)	3 (2–5)	0.01^*
Parity (number)	1 (1–2)	2 (1–2)	0.02^*
Abortus (number)	0 (0–1)	0 (0–1)	0.65
Previous C/S (number)	0 (0–1)	0 (0–1)	0.14
Previous preterm delivery	42 (21.4)	42 (20.6)	0.83
Hypertensive disorders	41 (20.9)	36 (17.6)	0.40
Fetal growth restriction	17 (8.7)	19 (9.3)	0.96
Oligohydramnios	12 (6.1)	17 (8.3)	0.51

BMI, body mass index; C/S, cesarean section; kg/m², kilograms per square meter
Data are expressed as median (Q1-Q3), or number (percentage) where appropriate. A p value of < 0.05 indicates a significant difference. Statistically significant p-values are indicated by the superscript asterisks. N is the total sample size consisted of patients

ISSN: 1471-2393